Suchergebnisse - "Subbiah, Vivek"

PubPharm (568)

81

BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

enthalten in: NPJ precision oncology | 2023

von Nelson, B. | Roszik, J. | Janku, F. | +13

82

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer

enthalten in: Journal of immunotherapy and precision oncology | 2023

von Son, J. | Lin, H. | Fu, S. | +17

83

RET aberrant cancers and RET inhibitor therapies : Current state-of-the-art and future perspectives

enthalten in: Pharmacology & therapeutics | 2023

von Addeo, A. | Miranda-Morales, E. | den Hollander, P. | +5

84

Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers

enthalten in: Therapeutic advances in medical oncology | 2023

von Gouda, M. | Subbiah, V.

85

International multicenter study comparing COVID-19 in patients with cancer to patients without cancer : Impact of risk factors and treatment modalities on survivorship

enthalten in: eLife | 2023

von Raad, I. | Hachem, R. | Masayuki, N. | +49

UpdateOf: medRxiv. 2022 Aug 26;:. - PMID 36097568

86

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia : phase I trials

enthalten in: Nature medicine | 2023

von Yap, T. | Daver, N. | Mahendra, M. | +46

CommentIn: Nat Med. 2023 Jan;29(1):29-30. - PMID 36658424

87

Examining Stripes on a Herd of Zebras : Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Moyers, J. | Pestana, R. | Roszik, J. | +20

88

The next generation of evidence-based medicine

enthalten in: Nature medicine | 2023

von Subbiah, V.

89

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery

enthalten in: Oncoscience | 2023

von Gouda, M. | Janku, F. | Somaiah, N. | +3

90

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

enthalten in: Oncoscience | 2023

von Gouda, M. | Zarzour, M. | Vaporciyan, A. | +3